Ubs Group Ag Moderna, Inc. Put Options Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

Put Options

19 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$63.64 - $125.14 $17.6 Million - $34.7 Million	277,000 Added 76.77%	637,800 $42.6 Million
Q2 2024 Aug 13, 2024	SELL	$101.21 - $166.61 $1.81 Million - $2.98 Million	-17,900 Reduced 4.73%	360,800 $42.8 Million
Q1 2024 May 13, 2024	SELL	$85.37 - $115.44 $30 Million - $40.6 Million	-351,900 Reduced 48.17%	378,700 $40.4 Million
Q4 2023 Feb 09, 2024	BUY	$69.51 - $104.43 $4.18 Million - $6.29 Million	60,200 Added 8.98%	730,600 $72.7 Million
Q3 2023 Nov 09, 2023	BUY	$96.41 - $126.61 $15.4 Million - $20.3 Million	160,000 Added 31.35%	670,400 $69.2 Million
Q2 2023 Aug 11, 2023	SELL	$118.5 - $160.53 $18.4 Million - $24.9 Million	-154,900 Reduced 23.28%	510,400 $62 Million
Q1 2023 May 12, 2023	BUY	$135.66 - $197.02 $51.6 Million - $74.9 Million	380,400 Added 133.52%	665,300 $102 Million
Q4 2022 Feb 08, 2023	SELL	$118.38 - $210.04 $4.96 Million - $8.8 Million	-41,900 Reduced 12.82%	284,900 $51.2 Million
Q3 2022 Nov 10, 2022	BUY	$118.07 - $194.18 $20.9 Million - $34.3 Million	176,800 Added 117.87%	326,800 $38.6 Million
Q2 2022 Aug 10, 2022	BUY	$117.13 - $176.59 $9.39 Million - $14.2 Million	80,200 Added 114.9%	150,000 $21.4 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $16.9 Million - $31.4 Million	-133,800 Reduced 65.72%	69,800 $12 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $5.53 Million - $9.03 Million	-24,500 Reduced 10.74%	203,600 $51.7 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $10.4 Million - $22.7 Million	-46,900 Reduced 17.05%	228,100 $87.8 Million
Q2 2021 Aug 13, 2021	SELL	$129.91 - $234.98 $8.07 Million - $14.6 Million	-62,100 Reduced 18.42%	275,000 $64.6 Million
Q1 2021 May 12, 2021	BUY	$109.18 - $185.98 $15 Million - $25.5 Million	137,000 Added 68.47%	337,100 $44.1 Million
Q4 2020 Feb 11, 2021	BUY	$65.74 - $169.86 $12.1 Million - $31.3 Million	184,400 Added 1174.52%	200,100 $20.9 Million
Q3 2020 Nov 12, 2020	BUY	$54.34 - $94.85 $847,704 - $1.48 Million	15,600 Added 15600.0%	15,700 $1.11 Million
Q2 2020 Jul 31, 2020	SELL	$29.67 - $80.0 $1.08 Million - $2.91 Million	-36,400 Reduced 99.73%	100 $6,000
Q1 2020 May 01, 2020	BUY	$17.78 - $31.58 $648,970 - $1.15 Million	36,500 New	36,500 $1.09 Million

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account